The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 12 08 2022
accepted: 24 03 2023
medline: 17 4 2023
entrez: 13 4 2023
pubmed: 14 4 2023
Statut: epublish

Résumé

The SARS-CoV-2 Alpha variant was associated with increased transmission relative to other variants present at the time of its emergence and several studies have shown an association between Alpha variant infection and increased hospitalisation and 28-day mortality. However, none have addressed the impact on maximum severity of illness in the general population classified by the level of respiratory support required, or death. We aimed to do this. In this retrospective multi-centre clinical cohort sub-study of the COG-UK consortium, 1475 samples from Scottish hospitalised and community cases collected between 1st November 2020 and 30th January 2021 were sequenced. We matched sequence data to clinical outcomes as the Alpha variant became dominant in Scotland and modelled the association between Alpha variant infection and severe disease using a 4-point scale of maximum severity by 28 days: 1. no respiratory support, 2. supplemental oxygen, 3. ventilation and 4. death. Our cumulative generalised linear mixed model analyses found evidence (cumulative odds ratio: 1.40, 95% CI: 1.02, 1.93) of a positive association between increased clinical severity and lineage (Alpha variant versus pre-Alpha variants). The Alpha variant was associated with more severe clinical disease in the Scottish population than co-circulating lineages.

Identifiants

pubmed: 37053201
doi: 10.1371/journal.pone.0284187
pii: PONE-D-22-22604
pmc: PMC10101505
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0284187

Subventions

Organisme : Medical Research Council
ID : MC_UU_12014/12
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19026
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00002/11
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V038613/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC UU 00002/11
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00034/6
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC UU 1201412
Pays : United Kingdom

Informations de copyright

Copyright: © 2023 Pascall et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet Microbe. 2020 Jul;1(3):e99-e100
pubmed: 32835336
Cell. 2021 Jan 7;184(1):64-75.e11
pubmed: 33275900
Clin Infect Dis. 2022 Aug 24;75(1):e1128-e1136
pubmed: 34423834
Euro Surveill. 2021 Mar;26(11):
pubmed: 33739254
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
Nature. 2021 Apr;592(7855):616-622
pubmed: 33567448
Nat Microbiol. 2021 Jan;6(1):112-122
pubmed: 33349681
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Nature. 2021 Apr;592(7853):277-282
pubmed: 33545711
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
BMJ Open Respir Res. 2021 Sep;8(1):
pubmed: 34544733
Nature. 2022 Feb;602(7897):487-495
pubmed: 34942634
BMJ Open. 2022 Feb 8;12(2):e055474
pubmed: 35135773
Euro Surveill. 2022 May;27(20):
pubmed: 35593163
Med Drug Discov. 2021 Jun;10:100086
pubmed: 33681755
Clin Infect Dis. 2022 Aug 24;75(1):e1120-e1127
pubmed: 34487522
Cell Host Microbe. 2021 Apr 14;29(4):529-539.e3
pubmed: 33705729
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Nat Microbiol. 2022 Aug;7(8):1161-1179
pubmed: 35798890
BMJ. 2021 Jun 15;373:n1412
pubmed: 34130987
Cell. 2021 Mar 4;184(5):1171-1187.e20
pubmed: 33621484
Cell Rep. 2021 Mar 23;34(12):108890
pubmed: 33713594
Lancet Infect Dis. 2021 Sep;21(9):1246-1256
pubmed: 33857406

Auteurs

David J Pascall (DJ)

MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
Joint Universities Pandemic and Epidemiological Research (JUNIPER) Consortium, United Kingdom.

Elen Vink (E)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
NHS Lothian, Edinburgh, United Kingdom.

Rachel Blacow (R)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.

Naomi Bulteel (N)

NHS Fife, Kirkcaldy, Fife, United Kingdom.

Alasdair Campbell (A)

NHS Lothian, Edinburgh, United Kingdom.

Robyn Campbell (R)

NHS Lothian, Edinburgh, United Kingdom.

Sarah Clifford (S)

NHS Lothian, Edinburgh, United Kingdom.

Chris Davis (C)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.

Ana da Silva Filipe (A)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.

Noha El Sakka (N)

NHS Grampian, Aberdeen, United Kingdom.

Ludmila Fjodorova (L)

NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.

Ruth Forrest (R)

NHS Fife, Kirkcaldy, Fife, United Kingdom.

Emily Goldstein (E)

NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.

Rory Gunson (R)

NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.

John Haughney (J)

NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.

Matthew T G Holden (MTG)

Public Health Scotland, Edinburgh, United Kingdom.
School of Medicine, University of St Andrews, St Andrews, Fife, United Kingdom.

Patrick Honour (P)

NHS Borders, Melrose, Scottish Borders, United Kingdom.

Joseph Hughes (J)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.

Edward James (E)

NHS Borders, Melrose, Scottish Borders, United Kingdom.

Tim Lewis (T)

NHS Lothian, Edinburgh, United Kingdom.

Samantha Lycett (S)

The Roslin Institute, University of Edinburgh, Midlothian, United Kingdom.

Oscar MacLean (O)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.

Martin McHugh (M)

NHS Lothian, Edinburgh, United Kingdom.

Guy Mollett (G)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.

Yusuke Onishi (Y)

NHS Grampian, Aberdeen, United Kingdom.

Ben Parcell (B)

School of Life Sciences, University of Dundee, Dundee, United Kingdom.

Surajit Ray (S)

School of Mathematics and Statistics, University of Glasgow, Glasgow, United Kingdom.

David L Robertson (DL)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.

Sharif Shabaan (S)

Public Health Scotland, Edinburgh, United Kingdom.

James G Shepherd (JG)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.

Katherine Smollett (K)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.

Kate Templeton (K)

NHS Lothian, Edinburgh, United Kingdom.

Elizabeth Wastnedge (E)

NHS Lothian, Edinburgh, United Kingdom.

Craig Wilkie (C)

School of Mathematics and Statistics, University of Glasgow, Glasgow, United Kingdom.

Thomas Williams (T)

NHS Lothian, Edinburgh, United Kingdom.
Royal Hospital for Children and Young People, University of Edinburgh, Edinburgh, United Kingdom.

Emma C Thomson (EC)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.
London School of Hygiene and Tropical Medicine, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH